Obstetrics and Gynecology
Shaimaa Abdulamer Nasir
Volume 9, Issue 2 , March and April 2024, , Pages 212-217
Abstract
Background & Objective: The aim of the current study was comparison of the effectiveness of intravenous iron sucrose versus oral ferrous fumarate for the treatment of iron deficiency anemia during pregnancy.Materials & Methods: This is a prospective randomized clinical trial enrolling ...
Read More
Background & Objective: The aim of the current study was comparison of the effectiveness of intravenous iron sucrose versus oral ferrous fumarate for the treatment of iron deficiency anemia during pregnancy.Materials & Methods: This is a prospective randomized clinical trial enrolling 100 pregnant women with iron deficiency anemia who visited the Al-diwaniya Educational Hospital for maternity and children from October 2022 to July 2023 whose ferritin level was less than 15 ng/ml and Hb level was between 70-10.9g/L. They were treated with either intravenous iron sucrose or oral ferrous fumarate for four weeks. Formerly, patients were allocated into two groups. The patients in the group I received ferrous fumarate pills, each enclosed with elemental Iron 100 mg. Group II got 100 ml of 0.9% NaCl containing a dose of iron sucrose dissolved in it and calculated by a specific equation. After four weeks, serum ferritin and hemoglobin levels were assessed, and the adverse effects were also monitored.Results: Comparing hemoglobin levels produces a substantial pre- and post-treatment difference (P=0.001). Serum Ferritin Level harvest significant differences pre- and post-treatment (P=0.001). The post-treatment comparison of the two groups showed a significant difference in each group (P= 0.001).Conclusion: Maternal iron reserves are more effectively increased by intravenous ferrous sucrose than by oral ferrous fumarate.
Obstetrics and Gynecology
Ali Abdulhussain Fadhil; Ghazi Mohamad Ramadan; Zahraa A. Al-Ajeeli; Noora M. Hameed; Wael Dheaa Kadhim; Ahmed S. Abed; Iman Hazim Jirjees; Anwar Sabbah Hussen
Volume 8, Issue 4 , July and August 2023, , Pages 374-381
Abstract
Background & Objective: Low and high hemoglobin concentration is one of the main concerns of women during pregnancy due to its high prevalence and adverse effects. The present study aimed to examine the correlation between maternal hemoglobin concentration and the baby's birth weight and height ...
Read More
Background & Objective: Low and high hemoglobin concentration is one of the main concerns of women during pregnancy due to its high prevalence and adverse effects. The present study aimed to examine the correlation between maternal hemoglobin concentration and the baby's birth weight and height in 326 pregnant women referred to the Alwiyah hospital for obstetrics and gynecology in Baghdad, Iraq, in 2019.Materials & Methods: In the current descriptive-analytical study, pregnant women were classified into two groups: anemia and normal; four groups of moderate to severe anemia, mild, regular, and high hemoglobin; and eight groups with intervals of 12 g/L from severe anemia to high hemoglobin. This study's variables included infants' age, number of children, education level, socioeconomic status, weight, and height. The data was analyzed using SPSS version 19, descriptive statistics, t-test, and logistic regression. In this study, the level of statistical significance was deemed to be 0.001.Results: The results showed that the probability of low birth weight and abnormal height increases 4.96 times and 4.13 times, respectively, in mothers with high hemoglobin concentrations versus mothers with low hemoglobin concentrations; these ratios are statistically significant (P<0.001). Also, hemoglobin concentrations ranging from 104 to 115 g/L have the lowest probability. Furthermore, hemoglobin concentrations greater than 125 g/L are statistically significant (P<0.001).Conclusion: The current study revealed that high maternal hemoglobin concentrations during pregnancy could significantly impact the baby's weight and height.
